Curaleaf reported a larger-than-expected quarterly loss per share, ending a recent run of earnings beats.
Curaleaf Holdings Inc. (TSX: CURA) reported adjusted earnings of -US$0.1729 per share for the quarter ended September 30, 2026. That was 15.3% below the -US$0.15 estimate. The company had beaten estimates in three of its previous four reported quarters, including the March and June quarters. The available earnings data does not include actual revenue or margin figures, so the EPS miss alone doesn’t explain what changed. For Canadian investors, the key question is whether this is a temporary setback or a sign of a longer-term challenge to profitability.
Recent earnings trend
Curaleaf Holdings Inc.
CURA.TO
CURA.TO
Curaleaf Holdings Inc.
WealthAwesomeMarket cap
$3.51B
52W high
$20.93
52W low
$7.77
1W change
+12.40%
Beta
1.76
Analyst Price Targets
Based on analyst covering CURA · as of Nov 9, 2026
Wall Street analysts forecast CURA stock price to rise 48.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$19.64
+48.5% Upside
Previously C$18.19 on Nov 6, 2026
Current Price
C$13.23
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CURA's historical volatility
30-Day Vol
63.6%
Annualized
90-Day Vol
60.8%
Annualized
Trend (90d)
-17.7%
Annualized drift
90d Mean
C$12.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$12.95 | C$10.40 – C$16.13 |
| 60 trading days | C$12.68 | C$9.30 – C$17.30 |
| 90 trading days | C$12.42 | C$8.49 – C$18.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 3 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-12-31 | 2027-02-25 | — | -0.2100 | — |
| 2026-09-30 | 2026-11-03 | -0.1729 | -0.1500 | -15.3% |
| 2026-06-30 | 2026-08-05 | 0.0700 | -0.2400 | +129.2% |
| 2026-03-31 | 2026-05-04 | 0.2900 | -0.2700 | +207.4% |
| 2025-12-31 | 2026-02-26 | -0.0500 | -0.0900 | +44.4% |
| 2025-09-30 | 2025-11-04 | -0.1900 | -0.2400 | +20.8% |
Investor takeaway: CURA’s latest miss breaks a generally strong recent record against estimates, but one quarter doesn’t establish a trend. Its trailing-twelve-month EPS is -US$0.07, and its profit margin is -0.76%, so profitability remains a work in progress. Investors should review the full operating results and management’s comments before drawing conclusions.
CURA’s quarterly loss per share was 15.3% wider than estimated
Curaleaf reported EPS of -US$0.1729, compared with the -US$0.15 estimate, for the quarter ended September 30. The company had beaten estimates in three of its previous four reported quarters. This result marks a break from that recent pattern.
Bull case
Curaleaf beat estimates in three of its last four reported quarters, with particularly large surprises in March and June 2026. The earnings calendar listed a revenue estimate of US$345.6 million, which implied 7.9% year-over-year growth. The actual revenue result wasn’t included in the available data. Recent company news also points to retail and market-development activity, including an equity stake in Boone Town Provisions in New Jersey and a program supporting independent dispensaries in New York.
Bear case
Curaleaf’s September-quarter loss was larger than expected, and the available data doesn’t include actual revenue, margins or management guidance to explain the miss. The company also remains unprofitable on a trailing basis. Its share price has ranged from C$7.77 to C$20.93 over the past 52 weeks, showing significant volatility. The latest supplied close, C$13.23, was below the 50-day moving average of C$13.44.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
